Geron Details RYTELO Growth Plan, $220M-$240M 2026 Sales Guide and MF Trial Catalyst at Barclays Conference

Executives from Geron (NASDAQ:GERN) outlined their commercial priorities for RYTELO (imetelstat) and provided updates on the ...
Technology Networks

Innovative Platform Can Detect Disease From a Drop of Blood

EpiTracing" has proved capable of detecting and tracing diseases from as little as 50 μl of human plasma, roughly a drop of ...
Frontiers

Osteoclast Heterogeneity in Aging: New Tools to Decode Bone Resorption and Remodeling

Bone remodeling is a dynamic and tightly regulated process that maintains skeletal integrity throughout life. Central to this process are osteoclasts, the ...

New liquid biopsy technology can detect disease from a drop of blood

An innovative platform developed by PKU researchers called "cf-EpiTracing" has proved capable of detecting and tracing ...